Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.009879 USD
−411.16 K USD
52.99 M USD
28.84 M
About Boule Diagnostics AB
Sector
Industry
CEO
Torben Nielsen
Website
Headquarters
Spanga
Founded
1996
IPO date
Jun 23, 2011
Identifiers
2
ISIN SE0011231158
Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. It offers automated blood cell counting systems for both the global human and veterinary market. The company was founded in 1992 and is headquartered in Spanga, Sweden.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BDABF is 3.510000 USD — it has decreased by −55.23% in the past 24 hours. Watch Boule Diagnostics AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Boule Diagnostics AB stocks are traded under the ticker BDABF.
We've gathered analysts' opinions on Boule Diagnostics AB future price: according to them, BDABF price has a max estimate of 0.73 USD and a min estimate of 0.73 USD. Watch BDABF chart and read a more detailed Boule Diagnostics AB stock forecast: see what analysts think of Boule Diagnostics AB and suggest that you do with its stocks.
BDABF reached its all-time high on Jun 2, 2017 with the price of 34.126900 USD, and its all-time low was 3.510000 USD and was reached on Mar 27, 2023. View more price dynamics on BDABF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BDABF stock is 123.36% volatile and has beta coefficient of 0.72. Track Boule Diagnostics AB stock price on the chart and check out the list of the most volatile stocks — is Boule Diagnostics AB there?
Today Boule Diagnostics AB has the market capitalization of 19.24 M, it has decreased by −2.27% over the last week.
Yes, you can track Boule Diagnostics AB financials in yearly and quarterly reports right on TradingView.
Boule Diagnostics AB is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
BDABF earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.01 USD resulting in a −26.34% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about Boule Diagnostics AB earnings.
Boule Diagnostics AB revenue for the last quarter amounts to 12.98 M USD, despite the estimated figure of 14.47 M USD. In the next quarter, revenue is expected to reach 13.06 M USD.
BDABF net income for the last quarter is 173.12 K USD, while the quarter before that showed 1.15 M USD of net income which accounts for −85.00% change. Track more Boule Diagnostics AB financial stats to get the full picture.
Like other stocks, BDABF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boule Diagnostics AB stock right from TradingView charts — choose your broker and connect to your account.